CoChat

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies

Open access
Fabricius, William A., Ramanathan, Muthalagu · 2016 · Advances in Hematology

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Allogenic hematopoietic cell transplantation (HSCT) is typically the preferred curative therapy for adult patients with acute myeloid leukemia, but its use has been reduced as a consequence of limited donor availability in the form of either matched-related donors (MRD) or matched-unrelated donors (MUD). Alternative options such as unrelated umbilical cord blood (UCB) transplantation and haploidentical HSCT have been increasingly studied in the past few decades to overcome these obstacles. A human leukocyte antigen- (HLA-) haploidentical donor is a recipient’s relative who shares an exact haplotype with the recipient but is mismatched for HLA genes on the unshared haplotype. These dissimilarities pose several challenges to the outcomes of the patient receiving such a type of HSCT, including higher rates of bidirectional alloreactivity and graft failure. In the past 5 years, however, several nonrandomized studies have shown promising results in terms of graft success and decreased rates of alloreactivity, in part due to newer grafting techniques and graft-versus-host disease (GVHD) prophylaxis. We present here a summary and review of the latest results of these studies as well as a brief discussion on the advantages and challenges of haploidentical HSCT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2016/5726132

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 41 · Cited by 46

Research works printed but not linked: 1

  1. 1991, Bone Marrow Transplantation, 7, 443

Metadata

Authors
Fabricius, W. A., & Ramanathan, M.
Affiliations
University of Massachusetts Chan Medical School (US)
Corresponding author
Ramanathan, Muthalagu
Venue
Advances in Hematology
Published
2016
Volume
2016
Pages
1-8
ISSN
  • 1687-9104 (ISSN-L)
  • 1687-9112
OpenAlex
W2289485549
Cited by
46
References
41
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 4 · 2017: 5 · 2016: 2
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • Advances in Hematology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
haploidentical hematopoietic stem cell transplantation, acute myeloid leukemia, graft failure, graft-versus-host disease prophylaxis, unrelated cord blood transplantation, donor availability, graft-versus-leukemia effect

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies. https://app.cochat.ai/papers/10.1155/2016/5726132
The paper
Fabricius, W. A., & Ramanathan, M. (2016). Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies. Advances in Hematology. https://doi.org/10.1155/2016/5726132

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.